Quantcast

Latest Memorial Sloan–Kettering Cancer Center Stories

2014-09-17 23:08:45

Memorial Sloan Kettering, MD Anderson and Brigham and Women’s Hospital Cited for Exemplary Services DALLAS (PRWEB) September 17, 2014 U.S. News and World Report recently recognized the top hospitals in the country, and three mesothelioma treatment centers made the magazine’s list of best cancer treatment facilities, the mesothelioma law firm Baron and Budd reports. The Memorial Sloan Kettering Cancer Center, University of Texas MD Anderson Cancer Center and Brigham and Women’s...

2014-09-16 08:29:45

Results Validating the Multi-Modal Mechanism of Action Would Provide the Basis for Differentiating LevoCap ER from other Pain Therapies NEW YORK, Sept. 16, 2014 /PRNewswire/ -- Relmada Therapeutics, Inc., (OTCBB: RLMD), a clinical-stage company developing novel therapies for the treatment of chronic pain, announced today that it has entered into an agreement with Memorial Sloan Kettering Cancer Center (MSKCC) in a series of animal studies for levorphanol, the active ingredient of...

2014-09-12 12:24:46

Founding partner Equinox and their instructors will lead participants on stationary bikes to support rare cancer research led by Memorial Sloan Kettering Cancer Center, which owns and operates Cycle for Survival. NEW YORK, Sept. 12, 2014 /PRNewswire/ -- Cycle for Survival, the nationwide movement to beat rare cancers, will bring hundreds of supporters to Times Square on September 19 for the second annual Times Square Takeover, an all-day celebration featuring high-energy stationary...

2014-09-10 08:31:55

SAN DIEGO, Sept. 10, 2014 /PRNewswire/ -- MabVax Therapeutics Holdings, Inc. (OTCQB: TELK), a clinical stage oncology drug development company, announced today it has entered into agreements with Memorial Sloan Kettering Cancer Center (MSK) and Juno Therapeutics (Juno) for the development of novel therapeutic products using antibody targeting sequences derived from the fully-human antibodies discovered using the Company's internally developed antibody discovery platform. Under the...

2014-09-04 16:27:07

Unique Multivalent WT1 Vaccine to be developed across hematological malignancies and solid tumors NEW YORK, Sept. 4, 2014 /PRNewswire/ -- SELLAS Life Sciences Group (SELLAS), a Swiss-based development-stage biopharmaceutical company today announced that it has signed an exclusive global collaboration and license agreement with Memorial Sloan Kettering Cancer Center (MSK) for the development, marketing, and commercialization of MSK's proprietary WT1 cancer vaccine. "This...

2014-09-03 08:35:05

LMOCF continues to fund research efforts and provides four ways to join the fight during National Ovarian Cancer Awareness Month NEW YORK, Sept. 3, 2014 /PRNewswire/ -- The Laura Mercier Ovarian Cancer Fund (LMOCF) commemorates National Ovarian Cancer Awareness Month by releasing new fundraising products and encouraging others to get involved with the cause. Ovarian cancer is the leading cause of death among gynecological cancers and fifth leading cause of death among women in the U.S.*...

2014-08-25 12:26:05

Contract Results from Recent Merger with MabVax Therapeutics, Inc. SAN DIEGO, Aug. 25, 2014 /PRNewswire/ -- Telik, Inc. (OTCQB: TELK), a clinical stage oncology drug development company that merged with MabVax Therapeutics, Inc. on July 8, 2014, announced today it has received a $1.5 million contract for the Phase 2 portion of a Small Business Innovation Research (SBIR) contract from the National Cancer Institute (NCI). The contract is intended to support a major portion of the...

2014-07-30 23:00:35

The Mesothelioma Applied Research Foundation (Meso Foundation), in collaboration with Penn’s Abramson Cancer Center, announced that on September 26th it will host a regional conference at the Penn's Abramson Cancer Center to bring together area experts in the field of mesothelioma Alexandria, VA (PRWEB) July 30, 2014 The Mesothelioma Applied Research Foundation (Meso Foundation), in collaboration with the Penn's Abramson Cancer Center, will host a regional conference on...

2014-07-10 16:25:14

HERRIMAN, Utah, July 10, 2014 /PRNewswire-USNewswire/ -- The Vascular Access Certification Corporation (VACC) has issued a call to action to hospitals throughout the country to consider encouraging professionals working in the field of vascular access to seek certification. Speaking on behalf of the VACC board of directors, Board President Hudson J. Garrett, Jr., PhD, MSN, MPH, FNP, VA- BC(TM), cited Memorial Sloan Kettering Cancer Center as an example for hospitals to follow. "The...

2014-07-09 08:28:09

Leading cancer center selects Allscripts dbMotion(TM) and renews Allscripts Sunrise(TM) relationship to facilitate exceptional community-based patient care CHICAGO, July 9, 2014 /PRNewswire/ -- Allscripts (NASDAQ: MDRX) announced today that Memorial Sloan Kettering Cancer Center (MSK) will deploy Allscripts dbMotion interoperability and population health analytics solutions, and extend its use of its population-health-enabled Allscripts Sunrise platform electronic health record...


Word of the Day
grass-comber
  • A landsman who is making his first voyage at sea; a novice who enters naval service from rural life.
According to the OED, a grass-comber is also 'a sailor's term for one who has been a farm-labourer.'